News & Analysis on Clinical Trial Services & Contract Research And Development
Advanced imaging in drug discovery aims to improve the success rate of drug development as the industry continues to tackle devastating diseases such as Alzheimer’s – but no research lab can do it alone, says Charles River managing director.
An online platform linking drugmakers with disease interventions could help pharma companies enter early phase trials, says IN-PART.
Citoxlab Group has acquired Xenometrics, a non-clinical contract research organization (CRO), as client requests continue to increase, says company president.
BioClinica has acquired MDDX Research and Informatics to provide sponsors and CROs access to medical imaging technology, which can determine patient clinical trial eligibility in under an hour, says founder.
Almac Group’s acquisition of BioClin Laboratories expands the company’s analytical services – a growing area of business due to increasing global client requirements, says CDMO.
Torrent Pharmaceuticals will buy Unichem Laboratories’ formulations business in India and Nepal, its fourth acquisition in as many years.
Revising India’s intermediates manufacturing sector will reduce its dependence on China for APIs, says Pharmexcil delegate.
Generic injectables are a solution to rising healthcare costs says Fresenius, which is expanding its US manufacturing network to benefit from the long-term growth prospects.